XOMA Corp (NASDAQ:XOMA)
| 17.01 Delayed Data As of May 31 |  -0.24 / -1.39%Today’s Change | 15.68 Today|||52-Week Range 32.09 | -7.55% Year-to-Date |
Latest XOMA News | Press Releases
| Insider Buying: Interim CEO Owen Hughes Acquires 2,000 Shares of XOMA Corp May 27 / GuruFocus News - Paid Partner Content | Insider Buying: Interim CEO Owen Hughes Acquires 2,000 Shares of XOMA Corp (XOMA) May 26 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 17.25 |
| Today’s open | 16.94 |
| Day’s range | 16.74 - 17.20 |
| Volume | 5,610 |
| Average volume (3 months) | 31,317 |
| Market cap | $200.7M |
Data as of 4:00pm ET, 05/31/2023
Growth & Valuation
| Earnings growth (last year) | -386.76% |
| Earnings growth (this year) | +27.53% |
| Earnings growth (next 5 years) | +36.00% |
| Revenue growth (last year) | -84.21% |
| P/E ratio | NM |
| Price/Sales | 34.84 |
| Price/Book | 1.94 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ALTAltimmune Inc | +0.04 | +1.00% |
| SGMOSangamo Therapeutics... | -0.02 | -2.18% |
| KZRKezar Life Sciences ... | -0.05 | -1.75% |
| VSTMVerastem Inc | -11.48 | -91.99% |
Data as of 4:00pm ET, 05/31/2023
Financials
| Next reporting date | August 8, 2023 |
| EPS forecast (this quarter) | -$0.53 |
| Annual revenue (last year) | $6.0M |
| Annual profit (last year) | -$17.1M |
| Net profit margin | -283.79% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Emeryville, California |
Forecasts
